Celularity Correlations

CELU Stock

USD 1.25 0.02 1.57%

The current 90-days correlation between Celularity and Reviva Pharmaceuticals Holdings is 0.36 (i.e., Weak diversification). The correlation of Celularity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Celularity Correlation With Market

Excellent diversification

The correlation between Celularity and DJI is -0.69 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Celularity and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Celularity Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celularity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

Moving together with Celularity Stock

0.77	DWTX	Dogwood Therapeutics	Pair Corr
0.65	EDIT	Editas Medicine Earnings Call This Week	Pair Corr
0.79	ABP	Abpro Holdings	Pair Corr
0.63	QSI	QuantumSi	Pair Corr
0.72	GNLX	Genelux Common	Pair Corr
0.91	IMRN	Immuron Ltd ADR	Pair Corr
0.75	KURA	Kura Oncology	Pair Corr
0.77	MBIO	Mustang Bio	Pair Corr
0.7	MREO	Mereo BioPharma Group	Pair Corr
0.68	ACXP	Acurx Pharmaceuticals LLC	Pair Corr

Moving against Celularity Stock

0.85	IMMP	Immutep Ltd ADR	Pair Corr
0.57	ENGN	enGene Holdings Common	Pair Corr
0.52	KYTX	Kyverna Therapeutics	Pair Corr
0.44	63E	ONWARD MEDICAL BV	Pair Corr
0.43	DSGN	Design Therapeutics	Pair Corr
0.63	MRKR	Marker Therapeutics	Pair Corr
0.62	ANNX	Annexon	Pair Corr
0.56	AVE	Avecho Biotechnology	Pair Corr
0.52	SLDB	Solid Biosciences LLC	Pair Corr
0.52	BOLT	Bolt Biotherapeutics	Pair Corr
0.48	RCKT	Rocket Pharmaceuticals	Pair Corr
0.48	AVCR	Avricore Health	Pair Corr
0.77	DBVT	DBV Technologies Downward Rally	Pair Corr
0.75	CADL	Candel Therapeutics	Pair Corr
0.68	SMFG	Sumitomo Mitsui Financial Normal Trading	Pair Corr
0.66	SMFNF	Sumitomo Mitsui Financial Normal Trading	Pair Corr

Related Correlations Analysis

	BCAB	RVPH	ANVS	FGEN	ATNM	BTAI	KZR	PYPD	TPST	GBIO
BCAB		0.73	0.53	0.61	0.6	0.38	0.32	-0.86	0.4	-0.55	BCAB
RVPH	0.73		0.46	0.68	0.52	0.62	0.22	-0.75	0.33	-0.54	RVPH
ANVS	0.53	0.46		0.17	0.61	0.61	0.53	-0.25	-0.42	-0.4	ANVS
FGEN	0.61	0.68	0.17		-0.07	0.4	-0.19	-0.76	0.54	-0.63	FGEN
ATNM	0.6	0.52	0.61	-0.07		0.39	0.67	-0.4	-0.05	-0.23	ATNM
BTAI	0.38	0.62	0.61	0.4	0.39		0.29	-0.29	0.03	-0.44	BTAI
KZR	0.32	0.22	0.53	-0.19	0.67	0.29		-0.08	-0.26	-0.08	KZR
PYPD	-0.86	-0.75	-0.25	-0.76	-0.4	-0.29	-0.08		-0.59	0.58	PYPD
TPST	0.4	0.33	-0.42	0.54	-0.05	0.03	-0.26	-0.59		-0.22	TPST
GBIO	-0.55	-0.54	-0.4	-0.63	-0.23	-0.44	-0.08	0.58	-0.22		GBIO
	BCAB	RVPH	ANVS	FGEN	ATNM	BTAI	KZR	PYPD	TPST	GBIO

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

RVPH	+ 0.73	BCAB
FGEN	+ 0.68	RVPH
KZR	+ 0.67	ATNM
BTAI	+ 0.62	RVPH
FGEN	+ 0.61	BCAB
ATNM	+ 0.61	ANVS

High negative correlations

PYPD	- 0.86	BCAB
PYPD	- 0.76	FGEN
PYPD	- 0.75	RVPH
GBIO	- 0.63	FGEN
TPST	- 0.59	PYPD
GBIO	- 0.55	BCAB

Risk-Adjusted Indicators

There is a big difference between Celularity Stock performing well and Celularity Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Celularity's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
BCAB	7.51	(1.15)	0.00	0.63	0.00	0.00	15.28	(18.87)	66.15
RVPH	5.54	(0.70)	0.00	(0.51)	0.00	0.00	10.71	(9.68)	57.05
ANVS	5.03	0.42	0.07	0.72	5.14	(6.21)	14.79	(9.57)	41.06
FGEN	2.66	(0.20)	0.00	2.82	0.00	0.00	4.33	(5.28)	28.75
ATNM	3.04	(0.24)	0.00	(0.32)	0.00	0.00	5.84	(5.43)	20.75
BTAI	4.18	(0.04)	(0.02)	(0.01)	4.96	(4.61)	9.42	(8.05)	25.30
KZR	0.75	0.05	(0.02)	0.29	0.99	(0.87)	1.60	(1.27)	7.79
PYPD	2.02	0.25	0.09	0.40	2.17	(2.34)	4.79	(4.53)	14.82
TPST	4.77	(1.75)	0.00	(1.85)	0.00	0.00	7.62	(9.56)	52.01
GBIO	1.60	(0.01)	(0.01)	0.08	2.17	(1.89)	3.39	(3.99)	14.01

Celularity Corporate Management

Carlos Ramirez	SVP Relations	Profile
Sharmila MD	Senior Safety	Profile
CFA CFA	Chief Officer	Profile
Tim Wilk	Senior Operations	Profile
Ramji Krishnan	Chief Officer	Profile
Bradley Glover	Ex COO	Profile
CPA MS	Treasurer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC